Drugs that target dynamic microtubules: a new molecular perspective.
Reads0
Chats0
TLDR
The effects of microtubule‐binding chemotherapeutic agents are reviewed from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of micro Tubule assembly or disassembly.Abstract:
Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle apparatus. As such, there is a wide variety of compounds currently in clinical use and in development that act as antimitotic agents by altering microtubule dynamics. Although these diverse molecules are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research. In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of microtubule assembly or disassembly. These “biological vectors” can thus be used as a spatiotemporal context to describe molecular mechanisms by which microtubule-targeting drugs work.read more
Citations
More filters
Journal ArticleDOI
3-Aryl/Heteroaryl-5-amino-1-(3',4',5'-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization.
Romeo Romagnoli,Filippo Prencipe,Paola Oliva,Stefania Baraldi,Pier Giovanni Baraldi,Andrea Brancale,Salvatore Ferla,Ernest Hamel,Roberta Bortolozzi,Giampietro Viola +9 more
TL;DR: A novel series of 1-(3',4',5'-trimethoxybenzoyl)-5-amino-1,2,4-triazoles were synthesized, and most of the tested compounds showed moderate to potent antiproliferative activities against a panel of solid tumor and leukemic cell lines.
Journal ArticleDOI
Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models
Surendra R. Punganuru,Hanumantha Rao Madala,Constantinos M. Mikelis,Anshuman Dixit,Viswanath Arutla,Kalkunte S. Srivenugopal +5 more
TL;DR: KSS19 represents a rational hybrid drug with clinical relevance to CRC by combining the COX-2 selective NSAID rofecoxib with the cis-stilbene found in combretastatin A4, a problematic, but potent antimicrotubule and anti-angiogenesis agent.
Journal ArticleDOI
Combretastatin analogues in cancer biology: A prospective view.
TL;DR: The accent here is on the signalling systems operated by the new derivatives and their biological effects with reference to cancer progression, and the import of mammalian target of rapamycin pathway, which co‐ordinates growth factor receptor signalling, epithelial‐mesenchymal transition activation and angiogenic signalling, is emphasised.
Journal ArticleDOI
Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents
Casey J. Maguire,Zhi Chen,Vani P. Mocharla,Madhavi Sriram,Tracy E. Strecker,Ernest Hamel,Heling Zhou,Ramona Lopez,Yifan Wang,Ralph P. Mason,David J. Chaplin,Mary Lynn Trawick,Kevin G. Pinney +12 more
TL;DR: Through a long-term program of structure activity relationship (SAR) driven inquiry, it was discovered that the dihydronaphthalene molecular scaffold provided access to small-molecule inhibitors of tubulin polymerization.
References
More filters
Journal ArticleDOI
Microtubules as a target for anticancer drugs.
Mary Ann Jordan,Leslie Wilson +1 more
TL;DR: Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy, and it is now known that at lower concentrations, microtubule-targeted drugs can suppress micro Tubule dynamics without changingmicrotubule mass; this action leads to mitotic block and apoptosis.
Journal ArticleDOI
Dynamic instability of microtubule growth
TL;DR: It is reported here that microtubules in vitro coexist in growing and shrinking populations which interconvert rather infrequently and this dynamic instability is a general property of micro Tubules and may be fundamental in explaining cellular microtubule organization.
Journal ArticleDOI
Microtubule polymerization dynamics
TL;DR: This review describes progress toward understanding the mechanism of dynamic instability of pure tubulin and discusses the function and regulation of microtubule dynamic instability in living cells.
Journal ArticleDOI
Kinesin and Dynein Superfamily Proteins and the Mechanism of Organelle Transport
TL;DR: This review focuses on the molecular mechanism of organelle transport in cells and describes kinesin and dynein superfamily proteins.
Journal ArticleDOI
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Raimond B. G. Ravelli,Benoît Gigant,Patrick A. Curmi,Isabelle Jourdain,Sylvie Lachkar,André Sobel,Marcel Knossow +6 more
TL;DR: Changes in the subunits of tubulin as it switches from its straight conformation to a curved one correlate with the loss of lateral contacts and provide a rationale for the rapid microtubule depolymerization characteristic of dynamic instability.
Related Papers (5)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet,Mary Ann Jordan +1 more